Brown Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$468K Sell
1,329
-160
-11% -$57K 0.18% 112
2025
Q4
$487K Sell
1,489
-27
-2% -$8.56K 0.18% 109
2025
Q3
$428K Buy
1,516
+29
+2% +$8.41K 0.16% 120
2025
Q2
$415K Sell
1,487
-13
-0.9% -$3.68K 0.16% 124
2025
Q1
$467K Sell
1,500
-132
-8% -$39K 0.19% 107
2024
Q4
$425K Buy
1,632
+362
+29% +$107K 0.17% 115
2024
Q3
$409K Sell
1,270
-1,147
-47% -$375K 0.17% 122
2024
Q2
$755K Buy
+2,417
New +$710K 0.34% 89

Other funds holding AMGN

Brown Financial Advisors's AMGN Position: Q1 2026 in Review

Brown Financial Advisors reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $57K and leaving 1,329 shares worth $468K. The position accounts for 0.18% of the portfolio, ranked #112.

Brown Financial Advisors first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $755K in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Brown Financial Advisors held 1,329 shares of Amgen worth $468K as of Q1 2026.
  • Brown Financial Advisors sold 160 Amgen shares in Q1 2026, an estimated $57K.
  • Amgen made up 0.18% of Brown Financial Advisors's portfolio in Q1 2026, its #112 holding.
  • Brown Financial Advisors first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • Brown Financial Advisors's Amgen position peaked at $755K in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Brown Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.